Results per Page:
Fred Hutch researchers discover an unknown soldier in defense against viruses
A gene better known for its role in cancer progression also plays a surprising role in mounting an immune defense against Zika virus
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
Numerous medical advances originate from U.S.-funded HIV research
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
Targeting the Integrator complex improves reactivation of HIV
From the Emerman Lab, Human Biology Division
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
Fred Hutch leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
Meta-analysis of 122 COVID-19 clinical trials cites need for strategies to address trial participation gaps
Dr. Larry Corey receives Alexander Fleming Award
Virologist honored by peers for his lifetime achievements against infectious diseases
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial
Researchers link mutations in coronavirus' internal machinery to higher risk of severe disease
Early COVID-19 patients were more likely to be hospitalized if virus carried genetic trait
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around